Hyperthermic intraperitoneal chemotherapy for the treatment of recurrent ovarian cancer in elderly women

By  

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol. 94, Iss. 4, 2015-04 ,pp. : 435-439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Intraperitoneal Chemotherapy as Primary Treatment of Advanced Ovarian Cancer:Efficacy, Toxicity, and Future Directions

By  

Reviews on Recent Clinical Trials, Vol. 2, Iss. 3, 2007-09 ,pp. : 169-173

Bentham Science Publishers

Access to resources Recommend Favorite

Chemotherapy Resistance as a Predictor of Progression-Free Survival in Ovarian Cancer Patients Treated with Neoadjuvant Chemotherapy and Surgical Cytoreduction Followed by Intraperitoneal Chemotherapy: A Southwest Oncology Group Study

By  

Oncology, Vol. 77, Iss. 6, 2010-02 ,pp. : 395-399

Karger

Access to resources Recommend Favorite

A Comparative Study of Intraperitoneal Carboplatin versus Intravenous Carboplatin with Intravenous Cyclophosphamide in Both Arms as Initial Chemotherapy for Stage III Ovarian Cancer

By  

Oncology, Vol. 56, Iss. 4, 1999-05 ,pp. : 291-296

Karger

Access to resources Recommend Favorite

Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Cancer with Incidental Bochdalek Hernia and Postoperative Bilateral Thalamic Infarct: A Case Report

By  

Case Reports in Oncology, Vol. 10, Iss. 1, 2017-03 ,pp. : 265-271

Karger

Access to resources Recommend Favorite